Comerica Securities’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-566
Closed -$44.6K 641
2022
Q4
$44.6K Buy
+566
New +$42.4K ﹤0.01% 740
2022
Q1
Sell
-5,191
Closed -$443K 495
2021
Q4
$443K Buy
5,191
+629
+14% +$49.1K 0.03% 343
2021
Q3
$345K Buy
4,562
+137
+3% +$10.9K 0.02% 378
2021
Q2
$360K Buy
4,425
+365
+9% +$29.8K 0.03% 368
2021
Q1
$320K Sell
4,060
-221
-5% -$17.3K 0.02% 401
2020
Q4
$366K Buy
4,281
+266
+7% +$22K 0.03% 341
2020
Q3
$310K Sell
4,015
-689
-15% -$52.5K 0.03% 344
2020
Q2
$345K Buy
4,704
+213
+5% +$15.1K 0.03% 323
2020
Q1
$298K Buy
4,491
+978
+28% +$69K 0.03% 317
2019
Q4
$242K Buy
+3,513
New +$240K 0.02% 393

Other funds holding CL

Comerica Securities's CL Position: Q1 2023 in Review

Comerica Securities sold out of Colgate-Palmolive (CL) in Q1 2023, closing a stake of 566 shares — an estimated $44.6K sold.

Comerica Securities first reported a position in CL in Q4 2019 and held it in 10 quarters. The position peaked at $443K in Q4 2021. 1,657 funds tracked by Wall St. Rank hold CL as of Q1 2023.

  • Comerica Securities reported no remaining Colgate-Palmolive position as of Q1 2023 after selling out during the quarter.
  • Comerica Securities sold 566 Colgate-Palmolive shares in Q1 2023, an estimated $44.6K.
  • Comerica Securities first reported a position in Colgate-Palmolive in Q4 2019 and held it in 10 quarters.
  • Comerica Securities's Colgate-Palmolive position peaked at $443K in Q4 2021.
  • 1,657 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2023.

Based on Comerica Securities's 13F filing for Q1 2023, filed 27 Apr 2023.